78 studies found for:    Cerebellar Degeneration
Show Display Options
RSS Create an RSS feed from your search for:
Cerebellar Degeneration
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration
Condition: Spinocerebellar Degenerations
Intervention: Drug: high-dose intravenous immunoglobulin (IVIG)
2 Withdrawn Intravenous Levetiracetam as First-line Anticonvulsive Treatment in Patients With Non-convulsive Status Epilepticus
Condition: Status Epilepticus, Non-Convulsive
Intervention: Drug: first-line i/v-levetiracetam
3 Completed Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
Condition: Spinocerebellar Ataxia Type 3
Interventions: Drug: varenicline;   Drug: placebo
4 Recruiting Immunotherapy of the Paraneoplastic Syndromes
Condition: Paraneoplastic Syndromes
Intervention: Drug: Tacrolimus (FK506)
5 Not yet recruiting Emotional Communication Disorders in Cerebellar Disease
Condition: Cerebellar Diseases
Interventions: Behavioral: Testing of emotional communication ability;   Procedure: magnetic resonance imaging (MRI) of the brain
6 Recruiting An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: Spinocerebellar Degeneration
Interventions: Drug: KPS-0373, High dose;   Drug: KPS-0373, Low dose
7 Recruiting A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: Spinocerebellar Degeneration
Interventions: Drug: KPS-0373, High dose;   Drug: KPS-0373, Low dose;   Drug: Placebo
8 Unknown  Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations
Conditions: Spinocerebellar Ataxias;   Spastic Paraplegias
Intervention:
9 Completed Coenzyme Q10 in Adult-Onset Ataxia
Condition: Sporadic Ataxia
Interventions: Drug: Placebo (sugar pill);   Drug: Coenzyme Q10
10 Recruiting Parkinsonism in Spinocerebellar Ataxia Type 6
Condition: Spinocerebellar Ataxia Type 6
Intervention:
11 Recruiting Gaze Holding in Cerebellar Patients
Conditions: Gaze Holding in Humans;   Rebound in Humans
Intervention: Other: visual stimulus to follow
12 Completed Neuromuscular Electrical Stimulation on Median Nerve Facilitates Low Motor Cortex Excitability in Human With Spinocerebellar Ataxia
Condition: Spinocerebellar Ataxia
Intervention: Device: Neuromuscular electrical stimulation
13 Recruiting PET Imaging Study of Neurochemical and Autonomic Disorders in Multiple System Atrophy (MSA)
Conditions: Multiple System Atrophy - Parkinsonian Subtype (MSA-P);   Multiple System Atrophy - Cerebellar Subtype (MSA-C)
Intervention:
14 Completed A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
Conditions: Dementia With Lewy Bodies;   Alzheimer's Disease;   Parkinson's Disease
Interventions: Drug: 18F-AV-133;   Drug: 18F-AV-45
15 Recruiting Clinical and Molecular Investigations Into Ciliopathies
Conditions: Autosomal Recessive Polycystic Kidney Disease;   Congenital Hepatic Fibrosis;   Caroli's Disease;   Polycystic Kidney Disease;   Joubert Syndrome;   Cerebro-Oculo-Renal Syndromes;   COACH Syndrome;   Senior-Loken Syndrome;   Dekaban-Arima Syndrome;   Cogan Oculomotor Apraxia;   Nephronophthisis;   Bardet-Biedl Syndrome;   Alstrom Syndrome;   Oral-Facial-Digital Syndrome
Intervention:
16 Recruiting Neural Mechanisms Engaged in Control of Eye Movements
Conditions: Degenerative Diseases of the Central Nervous System;   Ocular-motor and Vestibular Diseases
Intervention:
17 Completed A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: Spinocerebellar Degeneration
Interventions: Drug: KPS-0373;   Drug: Placebo
18 Completed Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: Spinocerebellar Degeneration
Intervention: Drug: KPS-0373
19 Recruiting A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: Spinocerebellar Degeneration
Interventions: Drug: KPS-0373, High dose;   Drug: KPS-0373, Low dose
20 Recruiting A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: Spinocerebellar Degeneration
Interventions: Drug: KPS-0373, High dose;   Drug: KPS-0373, Low dose

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years